In the News April 1, 2015

Investors’ Business Daily Quotes Jitty Malik on First FDA-approved Biosimilar

The Food and Drug Administration (FDA) has approved the first so-called biosimilar drug for use in the United States, paving the way for alternatives to an entire class of complex drugs.

“As the FDA becomes more comfortable … we’re going to see biosimilars get through a lot more easily,” predicted Jitty Malik, partner in Alston & Bird’s Intellectual Property Litigation Group who specializes in intellectual property and drug-approval issues. “The first one’s always the hardest to get through, because the FDA is more cautious – it’s uncharted territory.”
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.